EvaluatePharma Alpha is a cutting-edge, premium service quantifying market events and evaluating the impact on product, portfolio and company valuation.

Alpha is designed to increase your competitive advantage, positioning you ahead of key events with incisive analysis and innovative tools that quantify the potential impact on current valuation and future risk.

• Only online Interactive NPV Analyzer enabling you to model the impact of future events on product, portfolio and company valuation
• Unique global coverage of over 3500 product NPVs linked to share price and company valuation
• First comprehensive Calendar of Events tracking events set to impact shareholder value    
• Incisive daily analysis from EP Vantage a forward-looking comment and analysis service putting market developments into commercial context 
• Exclusive market analytics with over 98% coverage of all listed companies above $150m Market Cap.